Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Head & Neck|September 17, 2009
Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experienceAnne M Traynor, Gregory M Richards, Gregory K Hartig, et al.
The Annals of Thoracic Surgery|November 28, 2006
Brain metastases from esophageal cancer: a phenomenon of adjuvant therapy?Thomas W Rice, Deepak Khuntia, Lisa A Rybicki, et al.
International Journal of Radiation Oncology, Biology, Physics|September 18, 2007
Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning studyAlonso N Gutiérrez, David C Westerly, Wolfgang A Tomé, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|May 6, 2022
RapidPlan hippocampal sparing whole brain model version 2-how far can we reduce the dose?Hefei Liu, Ryan Clark, Anthony Magliari, et al.
International Journal of Radiation Oncology, Biology, Physics|December 18, 2010
Phase I trial of pelvic nodal dose escalation with hypofractionated IMRT for high-risk prostate cancerJarrod B Adkison, Derek R McHaffie, Søren M Bentzen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 16, 2010
Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: safety profile for RTOG 0933Vinai Gondi, Wolfgang A Tome, James Marsh, et al.
Technology in Cancer Research & Treatment|June 5, 2003
Factors associated with improved survival in patients with brain metastases from esophageal cancer: a retrospective reviewDeepak Khuntia, Ratna Sajja, Mark A Chidel, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2010
Phase I trial of simultaneous in-field boost with helical tomotherapy for patients with one to three brain metastasesGeorge Rodrigues, Slav Yartsev, Brian Yaremko, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2009
A comprehensive assessment by tumor site of patient setup using daily MVCT imaging from more than 3,800 helical tomotherapy treatmentsLeah K Schubert, David C Westerly, Wolfgang A Tomé, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2013
Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancerDonald M Cannon, Minesh P Mehta, Jarrod B Adkison, et al.
Pageof 6